Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights-Reference-Cited by-同舟云学术

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights

Published:2018-07-12 Issue:7 Volume:16 Page:1045-1058
ISSN:1570-159X
Container-title:Current Neuropharmacology
language:en
Short-container-title:CN

Author:

Khatua Soumen¹,Song Anne²,Sridhar Divyaswathi Citla³,Mack Stephen C.²

Affiliation:

1. Department of Pediatrics, MD Anderson Cancer Center, The University of Texas Health Science Center at Houston, Pediatrics Houston, Texas, United States

2. Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, The University of Texas Health Science Center at Houston, Pediatrics Houston, Texas, United States

3. Department of Pediatrics, The University of Texas Health Science Center at Houston, Pediatrics Houston, Texas, United States

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology,General Medicine

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights into medulloblastoma relapse;Pharmacology & Therapeutics;2024-08

2. Regulation of primary cilia disassembly through HUWE1-mediated TTBK2 degradation plays a crucial role in cerebellar development and medulloblastoma growth;Cell Death & Differentiation;2024-06-15

3. Identification and validation of a metabolism-related gene signature for predicting the prognosis of paediatric medulloblastoma;Scientific Reports;2024-03-30

4. FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis;The Journal of Pathology;2024-01-17

5. Evolution of neurosurgical advances and nuances in medulloblastoma therapy;Child's Nervous System;2023-12-19